ozwire,
Good post. I agree that it is only realistic to expect delays and issues in the process. I don't agree with making a blanket excuse for issues encountered purely because it is a new process.
Managements handling of the issues encountered can only be fairly judged on an issue by issue basis. In the handling of individual issues, MHM's management have performed questionably.
What are your assumptions behind a $4 price target?
Regarding the binary approach, the potential outcomes for MHM are far more varied than a all or nothing outcome. There is a lot of in between, ie. the internetional expansion proves to be less profitable than imagined.
The issues I have with this approach is there is a lot of room for confirmation bias to influence the resultant valuation. Each individual would have a 'biased' view as to the chances of each outcome. imo, this is why MHM is a gamble - because so many variables are simply unknown and 'valuations' are based purely on speculation.
- Forums
- ASX - By Stock
- VYS
- mhm current value??
VYS
vysarn limited
Add to My Watchlist
0.98%
!
51.5¢

mhm current value??, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
51.5¢ |
Change
0.005(0.98%) |
Mkt cap ! $271.6M |
Open | High | Low | Value | Volume |
51.0¢ | 52.0¢ | 48.5¢ | $208.7K | 416.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 142978 | 49.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.5¢ | 4500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 140978 | 0.495 |
1 | 100000 | 0.490 |
2 | 10600 | 0.485 |
1 | 10000 | 0.480 |
1 | 4000 | 0.475 |
Price($) | Vol. | No. |
---|---|---|
0.515 | 4500 | 1 |
0.520 | 140000 | 2 |
0.525 | 100000 | 2 |
0.530 | 110102 | 3 |
0.540 | 47100 | 2 |
Last trade - 15.56pm 04/07/2025 (20 minute delay) ? |
Featured News
VYS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online